GleamWall
中文EN

QTI QT IMAGING HOLDINGS, INC.

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1844505 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY220.0%
TTM net income YoY8.2%
TTM EPS YoY58.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin40.4%
Operating margin-24.8%
Net margin-77.3%
FCF margin-48.2%
EBITDA margin-24.5%

Returns

ROE-2,125.0%
ROA-96.6%
ROIC (approx.)-98.7%
Asset turnover1.25x

Leverage & solvency

Liabilities / assets92.7%
Debt / equity5.07x
Current ratio3.10x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.61x
Accruals ratio-37.6%
Payout ratio—
Capex / revenue1.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$7.34M$7.43M$6.53M$8.28M$4.19M$3.66M$2.80M$846,497
Cost of revenue$4.31M$4.38M$3.86M$5.13M$2.39M$1.83M$986,000$446,586
Gross profit$3.03M$3.06M$2.67M$3.14M$1.80M$1.83M$1.81M$399,911
R&D expense$1.72M$1.62M$1.72M$1.24M$939,000$901,000$852,000$774,498
SG&A expense$3.75M$3.30M$3.30M$2.60M$2.52M$1.97M$2.00M$1.68M
Operating income-$2.45M-$1.86M-$2.35M-$700,211-$1.65M-$1.04M-$1.04M-$2.05M
Pretax income-$297,000-$11.07M—-$1.39M-$4.56M-$4.00M—-$3.50M
Income tax$0$2,000—-$3,782$0$3,000—-$15,783
Net income-$297,000-$11.07M-$3.41M-$1.39M-$4.56M-$4.00M-$11.14M-$3.49M
EBITDA-$2.39M-$1.84M-$2.33M-$684,211-$1.61M-$1.00M-$1.00M-$2.02M
EPS (basic)-0.02-0.75-0.25—-0.47-0.42-1.21—
EPS (diluted)-0.02-0.75-0.25—-0.47-0.42-1.21—
Weighted avg. shares (diluted)15.89M14.83M13.80M—9.60M9.45M9.17M—
Balance sheet
Cash & equivalents$8.12M$10.92M$6.90M$10.41M$1.72M$2.02M$3.01M$1.17M
Receivables$7.34M$7.40M$6.35M$5.78M$3.24M$3.65M$2.78M$67,000
Inventory$11.48M$9.87M$6.83M$5.03M$5.24M$3.23M$2.87M$3.14M
Current assets$28.20M$29.42M$21.20M$22.09M$11.29M$10.67M$9.81M$4.92M
PP&E, net$889,000$793,000$315,000$318,000$127,127$166,676$163,759$196,000
Total assets$30.52M$30.63M$22.03M$23.02M$12.12M$11.63M$10.86M$6.09M
Current liabilities$10.16M$9.50M$8.53M$7.87M$12.74M$6.31M$5.28M$9.79M
Long-term debt$11.40M$11.40M$10.10M$10.11M$15.12M$10.14M$10.16M$9.93M
Total debt$11.40M$11.40M$10.10M$10.11M$15.12M$10.14M$10.16M$9.93M
Total liabilities$27.87M$28.38M$18.23M$16.58M$21.20M$11.96M$31.07M$15.62M
Shareholders' equity$2.65M$2.25M$3.80M$6.45M-$9.07M-$324,000-$20.21M-$9.54M
Net debt$3.27M$473,000$3.20M-$303,000$13.41M$8.11M$7.16M$8.76M
Shares outstanding14.67M13.77M12.04M11.90M9.67M28.64M27.65M8.93M
Cash flow statement
Operating cash flow-$2.19M-$4.84M-$3.65M-$3.10M-$879,000-$1.44M-$3.54M-$1.23M
Capital expenditure$72,000$174,000$17,000$77,182$0$46,818$0$53,200
Free cash flow-$2.26M-$5.01M-$3.67M-$3.18M-$879,000-$1.49M-$3.54M-$1.28M
Investing cash flow-$72,000-$174,000-$17,000-$77,182$0-$46,818$0-$53,200
Financing cash flow-$291,000$9.04M$159,000$11.91M$572,000$524,000$5.35M$908,210
Depreciation & amortization$55,000$21,000$20,000$16,000$40,000$38,000$38,000$26,717
Stock-based compensation$731,000$668,000$381,000$282,279$199,000$219,000$101,000$123,608

Free plan shows the latest 8 periods; Pro shows all 22 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.